Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is common among female health science students, linked to hormonal issues and family history, and early diagnosis is important.

Men with a family history of PCOS have lower sperm concentration and more hair loss.

Young women with PCOS and no other heart risk factors have normal heart function.

The enzyme myo-inositol oxygenase is not linked to the cause of polycystic ovarian syndrome.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Indian women with PCOS from Delhi and Srinagar show different symptoms, with Delhi women having higher obesity and blood sugar issues, and Srinagar women showing more hair growth and testosterone levels.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Women with acne and hair loss, even if they have regular periods, often have polycystic ovary syndrome.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

The article concludes that global standardization in PCOS research is crucial for accurate diagnosis and understanding of the condition.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Women with PCOS experience more psychological symptoms and need emotional support.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and need specific interventions to improve it.

Screening for reproductive health issues like endometriosis, PCOS, and STDs is crucial for early detection and prevention.

ADAM17 could be a potential target for treating PCOS.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

The questionnaire is valid and reliable but needs more testing for future predictions.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Vitamins B3, B6, C, and iron intake affect hormone levels in women with certain types of PCOS.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Acne in reproductive-age women may be linked to conditions like PCOS and lifestyle factors, so doctors should check for these when treating acne.

Anabolic-androgenic steroids can harm women's health and their offspring.